Latest Intelligence

Published within

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

Type Product title / description Pub Price
NewsWire
NewsWire

Getinge Q2 net profit down

Getinge Group, a provider of healthcare products, has reported that net profit attributable to parent company shareholders for the second quarter ended June 30, 2014 was SEK397 million, or SEK1.67 per share, compared to SEK455 million, or SEK1.91 per share, for the second quarter ended June 30, 2013.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Global Health Partner Q2 net profit up

Global Health Partner AB, a provider of healthcare services, has reported that net profit attributable to parent company shareholders for the second quarter ended June 30, 2014 was SEK7.4 million, or SEK0.11 per share, compared to SEK3.8 million, or SEK0.06 per share, for the second quarter ended June 30, 2013.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

HealthCare Partners president and CEO to step down

DaVita HealthCare Partners Inc., a provider of kidney care and health care services, has announced that Craig Samitt, president and CEO of HealthCare Partners, or HCP, is stepping down from HCP effective August 1, 2014.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Welch Allyn launches new scoring app for Connex Vital Signs Monitor

Welch Allyn, a medical diagnostic device company, has announced a new scoring app for its Connex Vital Signs Monitor, or VSM.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Lorus Therapeutics Q4 net loss up

Lorus Therapeutics Inc., a clinical-stage biotechnology company, has reported that net loss and total comprehensive loss for the fourth quarter ended May 31, 2014 was C$4.22 million, or C$0.04 loss per share, compared to a net loss and total comprehensive loss of C$1.32 million, or C$0.03 loss per share, for the fourth quarter ended May, 31 2013.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Medivir's sNDA for hepatitis C drug receives FDA priority review designation

Medivir AB, an emerging research-based pharmaceutical company, has received a priority review designation to the supplemental new drug application, or sNDA, from the FDA, for the use of once-daily Olysio in combination with sofosbuvir for 12 weeks treatment of adult patients with genotype 1 chronic hepatitis C.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Arena enters into marketing and supply agreement with Teva for obesity drug

Arena Pharmaceuticals, Inc. has announced that its subsidiary, Arena Pharmaceuticals GmbH, has entered into an exclusive marketing and supply agreement for BELVIQ with Teva Pharmaceutical Industries Limited's Israeli subsidiary, Abic Marketing Limited.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Zynex appoints new CFO

Zynex, Inc., a medical technology company, has appointed Brian Alleman as its new CFO.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

Magellan to offer expanded computerized cognitive behavioral therapy programs

Magellan Health, Inc., a provider of managed healthcare services, has announced that it will offer expanded computerized cognitive behavioral therapy programs for individuals managing medical and behavioral health issues, including addictions, anxiety disorders, obsessive compulsive disorder, or OCD, depression and insomnia.

Published By MarketLine
23 Jul 2014
NewsWire
NewsWire

URMC selects Medline as distributor for medical and surgical supplies

The University of Rochester Medical Center, or URMC, has selected Medline Industries, Inc., a distributor of healthcare supplies, as its prime vendor distributor for medical and surgical supplies.

Published By MarketLine
23 Jul 2014

« | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | ... | » »|

No help is available.